OncoCyte Corporation announced a private placement that it will receive funding of $3,500,000 on June 24, 2024. The transaction will include participation from returning investor, Bio-Rad Laboratories, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
273.1 USD | +0.41% |
|
-5.16% | -15.42% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.42% | 7.82B | |
-5.60% | 182B | |
-4.45% | 102B | |
-4.15% | 66.74B | |
-8.63% | 45.55B | |
+9.70% | 44.89B | |
+6.13% | 40.62B | |
+15.22% | 30.04B | |
+14.80% | 24.34B | |
-6.46% | 23.95B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- OncoCyte Corporation announced that it expects to receive $3.5 million in funding from Bio-Rad Laboratories, Inc.